Top Scientist Warns One Pfizer Shot Has Enough Rogue DNA To Cause Cancer!

Written by Elizabeth Carter.

Vaccines should protect us, not threaten our health. Yet, a leading biochemist’s findings have sparked a massive concern over Pfizer’s COVID-19 mRNA vaccine. It’s been revealed that just one dose might carry enough rogue DNA to risk cancer. This isn’t just speculation. Dr. Phillip Buckhaults, a name synonymous with excellence in biochemistry and cancer research, laid bare the unsettling truth during a testimony that’s shaking the foundations of what we thought we knew about Pfizer’s vaccine.

The Unwelcome Discovery

Dr. Buckhaults, during his detailed investigation, found that Pfizer’s vaccine is more than just an mRNA delivery system. Shockingly, it’s packed with plasmid DNA. We’re talking about a staggering 200 billion DNA fragments per dose. This isn’t just a minor oversight; it’s a glaring hazard that could compromise our genetic integrity, potentially leading to cancer.

The Science Behind the Concern

What’s truly alarming is the nature of these rogue DNA fragments. They have the potential to blend with our genetic makeup, posing a persistent risk of cancer and genetic mutations. Dr. Buckhaults pointed out that Pfizer’s attempt to minimize this risk by breaking up the DNA only made matters worse, increasing the likelihood of genetic alterations in those vaccinated.

The Origin of the Threat

This troubling DNA originates from a plasmid known as Agilent, which Pfizer uses in the vaccine’s development process. Despite efforts to purify the vaccine, significant amounts of this DNA remained, hidden within lipid nanoparticles. These particles are designed to fuse with our cells, making the potential for DNA integration a real and present danger.

Our Take

The revelations from Dr. Buckhaults and the validation from a Nobel Prize-winning scientist like Dr. Luc Montagnier highlight a critical oversight in the rush to vaccinate. It raises serious questions about the integrity of the vaccine’s development process and Pfizer’s transparency with the public. At a time when trust in our healthcare institutions is paramount, such findings underline the need for vigilance and a conservative approach to medical innovation. As conservatives, we advocate for the sanctity of individual health and the right to be fully informed about what enters our bodies. This situation serves as a reminder of why due diligence and skepticism towards big pharmaceutical companies are not just warranted but necessary.

Trending Stories:

Our Sponsors: